Dexcom (DXCM) Current Leases (2019 - 2026)

Dexcom (DXCM) has 8 years of Current Leases data on file, last reported at $20.5 million in Q1 2026.

• Current Leases for Q1 2026 came in at $20.5 million, down 9.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.5 million (down 9.29% YoY), and the FY2025 annual result was $21.6 million, down 4.0% from the prior year.
• Current Leases declined to $20.5 million in Q1 2026 per DXCM's latest filing, from $21.6 million in the prior quarter.
• Over five years, Current Leases peaked at $23.6 million in Q3 2025 and troughed at $20.5 million in Q4 2022.
• A 5-year average of $21.7 million and a median of $21.6 million in 2024 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2026: Current Leases climbed 14.84% in 2022, then retreated 9.29% in 2026.
• A 5-year view of Current Leases shows it stood at $20.5 million in 2022, then advanced by 2.93% to $21.1 million in 2023, then advanced by 6.64% to $22.5 million in 2024, then declined by 4.0% to $21.6 million in 2025, then fell by 5.09% to $20.5 million in 2026.
• Business Quant data shows DXCM's Current Leases at $20.5 million in Q1 2026, $21.6 million in Q4 2025, and $23.6 million in Q3 2025.